The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer
Open accessPublished version of a preprint
Abstract
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020. A familial aggregation of pancreatic cancer has been established, but the cause of this aggregation in most families is unknown. To determine the genetic basis of susceptibility in these families, we sequenced the germline genomes of 638 patients with familial pancreatic cancer and the tumor exomes of 39 familial pancreatic adenocarcinomas. Our analyses support the role of previously identified familial pancreatic cancer susceptibility genes such as BRCA2, CDKN2A, and ATM, and identify novel candidate genes harboring rare, deleterious germline variants for further characterization. We also show how somatic point mutations that occur during hematopoiesis can affect the interpretation of genome-wide studies of hereditary traits. Our observations have important implications for the etiology of pancreatic cancer and for the identification of susceptibility genes in other common cancer types. Significance: The genetic basis of disease susceptibility in the majority of patients with familial pancreatic cancer is unknown. We whole genome sequenced 638 patients with familial pancreatic cancer and demonstrate that the genetic underpinning of inherited pancreatic cancer is highly heterogeneous. This has significant implications for the management of patients with familial pancreatic cancer. Cancer Discov; 6(2); 166–75. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 109
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deleterious variants in the known pancreatic cancer susceptibility genes account for ~10–20% of the familial clustering of pancreatic cancer.”
In the citing paper
“Pancreatic surveillance is recommended for carriers of germline deleterious variants in cancer susceptibility gene,22–26: BRCA2, ATM, BRCA1, PALB2, CDKN2A, STK11, MLH1 and MSH2.”
In the citing paper
“Our data show, for the first time, that predisposition to MPM is very heterogeneous, similar to that reported for pancreatic cancer and other cancer types [17,18,38].”
From Germline Mutations in DNA Repair Genes Predispose Asbestos-Exposed Patients to Malignant Pleural Mesothelioma (2017) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Self-citationMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Cited by
Sorted by citations
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
Self-citationPancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258
Self-citationPancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Wood, L. D., Canto, M. I., Jaffee, E. M., & Simeone, D. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.056 · Cited by 918
Self-citationGoggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
Self-citationStoffel, E. M., Brand, R. E., & Goggins, M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.012 · Cited by 565
Self-citationStoop, T. F., Javed, A. A., Oba, A., Koerkamp, B. G., Seufferlein, T. T. W., Wilmink, J. W., & Besselink, M. G. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00261-2 · Cited by 601
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458
Self-citationAdvances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., You, L., Zhang, T., Dai, M., & Zhao, Y. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.027 · Cited by 495
Pancreatic cancer biology and genetics from an evolutionary perspective
Makohon-Moore, A. P., & Iacobuzio–Donahue, C. A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.66 · Cited by 436
Self-citationReal-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
Aguirre, A. J., Nowak, J. A., Camarda, N. D., Moffitt, R. A., Ghazani, A. A., Hazar-Rethinam, M., Raghavan, S., Kim, J., Brais, L. K., Ragon, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0275 · Cited by 367
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
Lowery, M. A., Wong, W., Jordan, E. J., Lee, J. W., Kemel, Y., Vijai, J., Mandelker, D., Zehir, A., Capanu, M., Salo-Mullen, E., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy024 · Cited by 224
Self-citationLowery, M. A., Jordan, E., Baştürk, O., Ptashkin, R. N., Zehir, A., Berger, M. F., Leach, T., Herbst, B. T., Askan, G., Maynard, H., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0899 · Cited by 212
Self-citationChen, J., Sun, Y., Xu, X., Wang, D., He, J., Zhou, H., Lu, Y., Zeng, J., Du, F., Gong, A., et al. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1380125 · Cited by 211
The pancreatic cancer genome revisited
Hayashi, A., Hong, J., & Iacobuzio-Donahue, C. A. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00463-z · Cited by 211
Self-citationEarly detection of pancreatic cancer: Where are we now and where are we going?
Zhou, B., Xu, J., Cheng, Y., Gao, J., Hu, S., Wang, L., & Zhan, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30670 · Cited by 218
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
Perkhofer, L., Gout, J., Roger, É., de Almeida, F. K., Simões, C., Wiesmüller, L., Seufferlein, T. T. W., & Kleger, A. (2020) · Gut · doi:10.1136/gutjnl-2019-319984 · Cited by 207
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Stoffel, E. M., McKernin, S. E., Brand, R. E., Canto, M. I., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M. B. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01489 · Cited by 205
Self-citationPancreatic Cancer Surveillance and Survival of High-Risk Individuals
Blackford, A. L., Canto, M. I., Dbouk, M. H., Hruban, R. H., Katona, B. W., Chak, A., Brand, R. E., Syngal, S., Farrell, J. J., Kastrinos, F., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1930 · Cited by 178
Self-citationPancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development
Dreyer, S. B., Chang, D. K.-F., Bailey, P. J., & Biankin, A. V. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2411 · Cited by 168
Petersen, G. M. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.09.002 · Cited by 157
Self-citationChaffee, K. G., Oberg, A. L., McWilliams, R. R., Majithia, N., Allen, B. A., Kidd, J., Singh, N., Hartman, A.-R., Wenstrup, R. J., & Petersen, G. M. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.85 · Cited by 144
Self-citationMicroenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Dauer, P., Nomura, A., Saluja, A., & Banerjee, S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.12.010 · Cited by 152
Scher, H. I., Graf, R. P., Schreiber, N. A., McLaughlin, B., Jendrisak, A., Wang, Y., Lee, J. S. H., Greene, S. B., Krupa, R., Lu, D. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1353 · Cited by 136
Self-citationSurgical and molecular pathology of pancreatic neoplasms
Hackeng, W. M., Hruban, R. H., Offerhaus, G. J. A., & Brosens, L. A. A. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0497-z · Cited by 133
Self-citationPrecancerous neoplastic cells can move through the pancreatic ductal system
Makohon-Moore, A. P., Matsukuma, K., Zhang, M., Reiter, J. G., Gerold, J. M., Jiao, Y., Sikkema, L., Attiyeh, M. A., Yachida, S., Sandone, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0481-8 · Cited by 120
Self-citationEarly detection of pancreatic cancer using DNA-based molecular approaches
Singhi, A. D., & Wood, L. D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00470-0 · Cited by 127
Self-citationRecent insights into the biology of pancreatic cancer
Yao, W., Maitra, A., & Ying, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102655 · Cited by 127
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Pelosi, E., Castelli, G., & Testa, U. (2017) · Biomedicines · doi:10.3390/biomedicines5040065 · Cited by 128
Why is pancreatic cancer so deadly? The pathologist's view
Hruban, R. H., Gaida, M. M., Thompson, E., Hong, S., Noë, M., Brosens, L. A., Jongepier, M., Offerhaus, G. J. A., & Wood, L. D. (2019) · The Journal of Pathology · doi:10.1002/path.5260 · Cited by 115
Self-citationPerkhofer, L., Schmitt, A., Carrasco, M. C. R., Ihle, M., Hampp, S., Ruess, D. A., Heßmann, E., Russell, R., Lechel, A., Azoitei, N., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0634 · Cited by 113
Breunig, M., Merkle, J., Wagner, M., Melzer, M. K., Barth, T. F. E., Engleitner, T., Krumm, J., Wiedenmann, S., Cohrs, C. M., Perkhofer, L., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.005 · Cited by 115
Mekonnen, N., Yang, H., & Shin, Y. K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.880643 · Cited by 117
Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Wang, S., Li, Y., Cheng, X., Ding, C., Zhang, H., Chen, L., You, L., Dai, M., & Zhao, Y. (2020) · PubMed Central · Cited by 107
The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families
Pilarski, R. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238977 · Cited by 115
Betti, M., Casalone, E., Ferrante, D., Aspesi, A., Morleo, G., Biasi, A., Sculco, M., Mancuso, G., Guarrera, S., Righi, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.028 · Cited by 101
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)
Chandana, S. R., Babiker, H. M., & Mahadevan, D. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1557145 · Cited by 102
Mutations in the pancreatic secretory enzymes CPA1 and CPB1 are associated with pancreatic cancer
Tamura, K., Yu, J., Hata, T., Suenaga, M., Shindo, K., Abe, T., MacGregor-Das, A., Borges, M., Wolfgang, C. L., Weiss, M. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720588115 · Cited by 95
Self-citationCombating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
Conway, J. R. W., Herrmann, D., Evans, T. J., Morton, J. P., & Timpson, P. (2018) · Gut · doi:10.1136/gutjnl-2018-316822 · Cited by 97
Genetics of familial and sporadic pancreatic cancer
Wood, L. D., Yurgelun, M. B., & Goggins, M. G. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.039 · Cited by 91
Self-citationRisk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene
Hsu, F.-C., Roberts, N. J., Childs, E., Porter, N., Rabe, K. G., Borgida, A., Ukaegbu, C., Goggins, M. G., Hruban, R. H., Zogopoulos, G., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3701 · Cited by 91
Self-citationParikh, A. R., He, Y., Hong, T. S., Corcoran, R. B., Clark, J. W., Ryan, D. P., Zou, L., Ting, D. T., Catenacci, D. V. T., Chao, J., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0034 · Cited by 92
Self-citationProspective study of germline genetic testing in incident cases of pancreatic adenocarcinoma
Brand, R. E., Borazanci, E. H., Speare, V., Dudley, B., Karloski, E., Peters, M. L. B., Stobie, L., Bahary, N., Zeh, H. J., Zureikat, A. H., et al. (2018) · Cancer · doi:10.1002/cncr.31628 · Cited by 88
Self-citationMetabolic Dependencies in Pancreatic Cancer
Gohar, A. V., Zarei, M., Brody, J. R., & Winter, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00617 · Cited by 87
BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma
Blair, A. B., Groot, V. P., Gemenetzis, G., Wei, J., Cameron, J. L., Weiss, M. J., Goggins, M., Wolfgang, C. L., Yu, J., & He, J. P. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.12.021 · Cited by 85
Self-citationAssessing aneuploidy with repetitive element sequencing
Douville, C. B., Cohen, J. D., Ptak, J., Popoli, M., Schaefer, J., Silliman, N., Dobbyn, L., Schoen, R. E., Tie, J., Gibbs, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910041117 · Cited by 82
Self-citationAdvances in Pancreatic Ductal Adenocarcinoma Treatment
Anderson, E. M., Thomassian, S., Gong, J., Hendifar, A. E., & Osipov, A. (2021) · Cancers · doi:10.3390/cancers13215510 · Cited by 78
HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer
Kalisz, M., Bernardo, E., Beucher, A., Maestro, M. A., del Pozo, N., Millán, I., Haeberle, L., Schlensog, M., Safi, S. A., Knoefel, W. T., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019102808 · Cited by 77
Germline mutations in Japanese familial pancreatic cancer patients
Takai, E., Yachida, S., Shimizu, K., Furuse, J., Kubo, E., Ohmoto, A., Suzuki, M., Hruban, R. H., Okusaka, T., Morizane, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12490 · Cited by 73
Self-citationEthical concerns on sharing genomic data including patients’ family members
Takashima, K., Maru, Y., Mori, S., Mano, H., Noda, T., & Muto, K. (2018) · BMC Medical Ethics · doi:10.1186/s12910-018-0310-5 · Cited by 72
Germline genetic variability in pancreatic cancer risk and prognosis
Gentiluomo, M., Canzian, F., Nicolini, A., Gemignani, F., Landi, S., & Campa, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.003 · Cited by 68
The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer
Kimura, H., Klein, A. P., Hruban, R. H., & Roberts, N. J. (2021) · Pancreas · doi:10.1097/mpa.0000000000001888 · Cited by 65
Self-citationSkaro, M. F., Nanda, N., Gauthier, C. D., Felsenstein, M., Jiang, Z., Qiu, M., Shindo, K., Yu, J., Hutchings, D., Javed, A. A., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.254 · Cited by 65
Self-citationJøergensen, M. T., Gerdes, A., Sørensen, J. R., de Muckadell, O. B. S., & Mortensen, M. B. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.013 · Cited by 63
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
Hamada, T., Yuan, C., Yurgelun, M. B., Perez, K., Khalaf, N., Morales-Oyarvide, V., Babic, A., Nowak, J. A., Rubinson, D. A., Giannakis, M., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0426-5 · Cited by 61
Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor
Takagi, M., Yoshida, M., Nemoto, Y., Tamaichi, H., Tsuchida, R., Seki, M., Uryu, K., Hoshino, N., Nishii, R., Miyamoto, S., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx062 · Cited by 63
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
Hu, C., LaDuca, H., Shimelis, H., Polley, E. C., Lilyquist, J., Hart, S. N., Na, J., Thomas, A., Lee, K. Y., Davis, B. T., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00291 · Cited by 57
Ohmoto, A., Yachida, S., & Morizane, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030561 · Cited by 58
Bazzichetto, C., Luchini, C., Conciatori, F., Vaccaro, V., Cello, I. D., Mattiolo, P., Falcone, I., Ferretti, G., Scarpa, A., Cognetti, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228841 · Cited by 58
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer
Nissim, S., Leshchiner, I., Mancias, J. D., Greenblatt, M. B., Maertens, O., Cassa, C. A., Rosenfeld, J. A., Cox, A. G., Hedgepeth, J., Wucherpfennig, J. I., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0475-y · Cited by 54
Self-citationNew Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis
Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59
Self-citationThe Significance of Liquid Biopsy in Pancreatic Cancer
Qi, Z.-H., Xu, H., Zhang, S.-R., Xu, J.-Z., Li, S., Gao, H.-L., Jin, W., Wang, W.-Q., Wu, C., Ni, Q., et al. (2018) · Journal of Cancer · doi:10.7150/jca.24591 · Cited by 60
Epigenetic Alterations in Pancreatic Cancer Metastasis
Wang, S. S., Xu, J., Ji, K. Y., & Hwang, C. (2021) · Biomolecules · doi:10.3390/biom11081082 · Cited by 50
Abe, K., Kitago, M., Kitagawa, Y., & Hirasawa, A. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02015-6 · Cited by 62
Rebelatto, T. F., Falavigna, M., Pozzari, M., Spada, F., Cella, C. A., Laffi, A., Pellicori, S., & Fazio, N. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.101895 · Cited by 50
Earl, J., Galindo-Pumariño, C., Encinas, J., Barreto, E., Castillo, M. E., Pachón, V., Ferreiro, R., Rodríguez-Garrote, M., González-Martínez, S., y Cajal, T. R., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102675 · Cited by 50
Afghani, E., & Klein, A. P. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.002 · Cited by 54
Self-citationDrosos, Y., Escobar, D., Chiang, M.-Y., Roys, K., Valentine, V. A., Valentine, M. B., Rehg, J. E., Sahai, V., Begley, L., Ye, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11661-8 · Cited by 51
Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
Gong, R., & Jiang, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00309 · Cited by 49
Germline Variants and Risk for Pancreatic Cancer
Zhan, W., Shelton, C. A., Greer, P. J., Brand, R. E., & Whitcomb, D. C. (2018) · Pancreas · doi:10.1097/mpa.0000000000001136 · Cited by 50
Self-citationFamilial Pancreatic Cancer: Current Perspectives
Llach, J., Carballal, S., & Moreira, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s172421 · Cited by 51
Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma
Llop, E., Guerrero, P. E., Duran, A., Barrabés, S., Massaguer, A., Ferri, M. J., Albiol-Quer, M., Llorens, R., & Peracaula, R. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i24.2537 · Cited by 47
Hahn, M., Vreede, L., Bemelmans, S. A. S. A., van der Looij, E., van Kessel, A. G., Schackert, H. K., Ligtenberg, M. J. L., Hoogerbrugge, N., Kuiper, R. P., & de Voer, R. M. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22385 · Cited by 46
Exome-Wide Association Study of Pancreatic Cancer Risk
Grant, R. C., Denroche, R. E., Borgida, A., Virtanen, C., Cook, N., Smith, A. L., Connor, A. A., Wilson, J. M., Peterson, G., Roberts, N. J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.015 · Cited by 46
Self-citationMiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3
Chang, W., Liu, M., Xu, J., Fu, H., Zhou, B., Yuan, T., & Chen, P. (2016) · Tumor Biology · doi:10.1007/s13277-016-5295-4 · Cited by 45
Next-Generation Sequencing in Pancreatic Cancer
Shen, G.-Q., Aleassa, E. M., Walsh, R. M., & Morris‐Stiff, G. J. (2019) · Pancreas · doi:10.1097/mpa.0000000000001324 · Cited by 45
The genomic landscape of familial glioma
Choi, D., Armstrong, G., Lozzi, B., Vijayaraghavan, P., Plon, S. E., Wong, T. C., Boerwinkle, E., Muzny, D. M., Chen, H., Gibbs, R. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade2675 · Cited by 45
Self-citationPancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49
Goldstein, J. B., Zhao, L., Wang, X., Ghelman, Y., Overman, M. J., Javle, M. M., Shroff, R. T., Varadhachary, G. R., Wolff, R. A., McAllister, F. M., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0224 · Cited by 46
Singh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 43
Targeting DNA damage repair pathways in pancreas cancer
Crowley, F., Park, W., & O’Reilly, E. M. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09983-1 · Cited by 43
Porter, N. R., Laheru, D. A., Lau, B. M., He, J. P., Zheng, L., Narang, A. K., Roberts, N. J., Canto, M. I., Lennon, A. M., Goggins, M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac167 · Cited by 44
Self-citationChen, F., Roberts, N. J., & Klein, A. P. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.12.04 · Cited by 42
Self-citationAlcaide, M., Cheung, M. C., Bushell, K. R., Arthur, S. E., Wong, H., Karasinska, J. M., Renouf, D. J., Schaeffer, D. F., McNamara, S., du Tertre, M. C., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.09.007 · Cited by 41
Cremin, C., Lee, M. K. C., Hong, Q., Hoeschen, C., Mackenzie, A., Dixon, K., McCullum, M., Nuk, J., Kalloger, S. E., Karasinska, J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.2973 · Cited by 41
Bhat, I. A., Kabeer, S. W., Reza, M. I., Mir, R. H., & Dar, M. O. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666191022102800 · Cited by 39
Tarannum, M., Hossain, M. A., Holmes, B. M., Yan, S., Mukherjee, P., & Vivero-Escoto, J. L. (2021) · Small · doi:10.1002/smll.202104449 · Cited by 43
Molina‐Montes, E., Gómez-Rubio, P., Márquez, M., Rava, M., Löhr, M. J., Michalski, C. W., Molero, X., Farré, A., Perea, J., Greenhalf, W., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyx269 · Cited by 39
Perkail, S., Andricovich, J., Yan, K., & Tzatsos, A. (2020) · Nature Communications · doi:10.1038/s41467-020-16589-8 · Cited by 41
Thompson, E. D., Roberts, N. J., Wood, L. D., Eshleman, J. R., Goggins, M., Kern, S. E., Klein, A. P., & Hruban, R. H. (2020) · Modern Pathology · doi:10.1038/s41379-020-0629-6 · Cited by 41
Self-citationHuang, H., He, M., Zhang, Y., Zhang, B., Niu, Z., Zheng, Y., Li, W., Cui, P., Wang, X., & Sun, Q. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00346-w · Cited by 39
Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
Espiau-Romera, P., Courtois, S., Parejo-Alonso, B., & Sancho, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124128 · Cited by 43
Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 41
Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer
Robless, E. E., Howard, J. A., Casari, I., & Falasca, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.005 · Cited by 37
Jellas, K. E., Hoem, D., Hagen, K. G., Kalvenes, M. B., Aziz, S. M., Steine, S. J., Immervoll, H., Johansson, S., & Molven, A. (2017) · Cancer Medicine · doi:10.1002/cam4.1097 · Cited by 37
Luongo, M., Marinelli, O., Zeppa, L., Aguzzi, C., Morelli, M. B., Amantini, C., Frassineti, A., di Costanzo, M., Fanelli, A., Santoni, G., et al. (2020) · Cancers · doi:10.3390/cancers12102774 · Cited by 42
Hereditary pancreatic cancer: related syndromes and clinical perspective
Carrera, S., Sancho, A., Azkona, E., Azkuna, J., & López-Vivanco, G. (2017) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-017-0069-6 · Cited by 36
Surveillance for pancreatic cancer in high‐risk individuals
Konings, I. C. A. W., Canto, M. I., Almario, J. A., Harinck, F., Saxena, P., Lucas, A. L., Kastrinos, F., Whitcomb, D. C., Brand, R. E., Lachter, J., et al. (2019) · BJS Open · doi:10.1002/bjs5.50180 · Cited by 36
Self-citationPan, M., Jiang, C., Zhang, Z., Achacoso, N. S., Alexeeff, S., Solorzano, A. V., Tse, P., Chung, E. H., Sundaresan, T. K., Suga, J. M., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00570 · Cited by 38
Glycogen synthase kinase-3β: a novel therapeutic target for pancreatic cancer
Ding, L., & Billadeau, D. D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1743681 · Cited by 35
Lim, C. H., Cho, Y. S., Choi, J. Y., Lee, K.-H., Lee, J. K., Min, J. H., & Hyun, S. H. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04698-x · Cited by 35
Metadata
- Authors
- Roberts, N. J., Norris, A. L., Petersen, G. M., Bondy, M. L., Brand, R., Gallinger, S., Kurtz, R. C., Olson, S. H., Rustgi, A. K., Schwartz, A. G., Stoffel, E., Syngal, S., Zogopoulos, G., Ali, S. Z., Axilbund, J., Chaffee, K. G., Chen, Y.-C., Cote, M. L., Childs, E. J., Douville, C., Goes, F. S., Herman, J. M., Iacobuzio-Donahue, C., Kramer, M., Makohon-Moore, A., McCombie, R. W., McMahon, K. W., Niknafs, N., Parla, J., Pirooznia, M., Potash, J. B., Rhim, A. D., Smith, A. L., Wang, Y., Wolfgang, C. L., Wood, L. D., Zandi, P. P., Goggins, M., Karchin, R., Eshleman, J. R., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Hruban, R. H., & Klein, A. P.
- Affiliations
- Howard Hughes Medical Institute (US)
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- 6Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Memorial Sloan Kettering Cancer Center (US)
- Abramson Cancer Center (US)
- Wayne State University (US)
- University of Michigan (US)
- Brigham and Women's Hospital (US)
- Research Institute of the McGill University Health Centre (CA)
- 3Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
- 15Department of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland.
- 10Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
- 19Memorial Sloan Kettering Cancer Center, New York, New York.
- Cold Spring Harbor Laboratory (US)
- 20Stanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
- University of Iowa (US)
- Corresponding author
- Roberts, Nicholas J.
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- ORCID
- Roberts, Nicholas J.
- Norris, Alexis L.
- Petersen, Gloria M.
- Bondy, Melissa L.
- Brand, Randall
- Kurtz, Robert C.
- Olson, Sara H.
- Rustgi, Anil K.
- Schwartz, Ann G.
- Stoffel, Elena
- Syngal, Sapna
- Zogopoulos, George
- Ali, Syed Z.
- Douville, Christopher
- Goes, Fernando S.
- Herman, Joseph M.
- Kramer, Melissa
- Makohon-Moore, Alvin
- Niknafs, Noushin
- Pirooznia, Mehdi
- Potash, James B.
- Rhim, Andrew D.
- Smith, Alyssa L.
- Wang, Yuxuan
- Wolfgang, Christopher L.
- Wood, Laura D.
- Zandi, Peter P.
- Goggins, Michael
- Karchin, Rachel
- Eshleman, James R.
- Papadopoulos, Nickolas
- Kinzler, Kenneth W.
- Vogelstein, Bert
- Hruban, Ralph H.
- Klein, Alison P.
- Venue
- Cancer Discovery
- Published
- 2016-02-01
- Volume
- 6
- Issue
- 2
- Pages
- 166-175
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4744563
- OpenAlex
- W2232697670
- Cited by
- 361
- References
- 49
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 42 · 2023: 33 · 2022: 30 · 2021: 58 · 2020: 41 · 2019: 43 · 2018: 35 · 2017: 32 · 2016: 18
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000371, 5p30ca045508-35)
- National Institute of Mental Health (R01MH087979, K01MH093809)
- National Cancer Institute (K99CA190889, R01CA-97075, R01-CA57345, R01CA154823, R00CA190889, R37CA043460, P50CA102701, R01CA057345, P30-CA045508, R01CA097075, R01CA177857, P50CA062924, R37CA057345, P30CA008748, P30CA015083, P30CA006973)
- National Institute of General Medical Sciences (T32GM007309, T32GM007057, T32GM008752)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK060694)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- familial pancreatic cancer, pancreatic ductal adenocarcinoma, germline mutations, cancer susceptibility genes, BRCA2, CDKN2A, ATM, somatic mutations, hematopoietic cells, genetic heterogeneity, hereditary cancer predisposition, rare deleterious variants
- MeSH terms
- Carcinoma, Humans, Pancreatic Neoplasms, Point Mutation, Sequence Analysis, DNA, Germ-Line Mutation, Cyclin-Dependent Kinase Inhibitor p16, Genetic Predisposition to Disease, BRCA2 Protein, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
